“
TL;DR
The central finding is that multiple candidate compounds show promise in experimental models for modulating RA-FLS proliferation and inflammatory cytokine production, though most remain at the preclinical stage.
Frontiers in Pharmacology · 6 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The central finding is that multiple candidate compounds show promise in experimental models for modulating RA-FLS proliferation and inflammatory cytokine production, though most remain at the preclinical stage.
The review highlights that MAPK and NF-κB remain the most commonly targeted pathways, while JAK/STAT inhibitors have already reached clinical use and Wnt modulation may offer dual benefits of bone repair and anti-inflammatory effects. The review underscores the need for further investigation into herbal extracts and Chinese herbal compound prescriptions for RA-FLS regulation.